Open Access
Yttrium-90-labelled somatostatin-analogue for cancer treatment
Andreas Otte
1
,
J Mueller-Brand
2, 3
,
S Dellas
2, 3
,
Eu Nitzsche
2, 3
,
R Herrmann
2, 3
,
Hr Maecke
2, 3
1
Institute of Nuclear Medicine, Department of Medical Radiology
3
and Department of Nuclear Medicine, University Hospital, Freiburg, Germany
|
Publication type: Journal Article
Publication date: 1998-02-01
scimago Q1
wos Q1
SJR: 12.113
CiteScore: 87.6
Impact factor: 88.5
ISSN: 01406736, 1474547X
PubMed ID:
9482300
General Medicine
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
2
4
6
8
10
12
14
16
|
|
|
Seminars in Nuclear Medicine
15 publications, 6.07%
|
|
|
European Journal of Nuclear Medicine and Molecular Imaging
13 publications, 5.26%
|
|
|
International Journal of Cancer
6 publications, 2.43%
|
|
|
Annals of Oncology
5 publications, 2.02%
|
|
|
Recent Results in Cancer Research
5 publications, 2.02%
|
|
|
Nuclear Medicine and Biology
4 publications, 1.62%
|
|
|
Cancer Biotherapy and Radiopharmaceuticals
4 publications, 1.62%
|
|
|
Nuclear Medicine Communications
4 publications, 1.62%
|
|
|
Cancer
4 publications, 1.62%
|
|
|
Clinical Cancer Research
4 publications, 1.62%
|
|
|
Medical radiology
4 publications, 1.62%
|
|
|
Journal of Medicinal Chemistry
3 publications, 1.21%
|
|
|
European Journal of Surgical Oncology
3 publications, 1.21%
|
|
|
Endocrine Reviews
3 publications, 1.21%
|
|
|
Journal of Nuclear Medicine
3 publications, 1.21%
|
|
|
Pharmaceuticals
3 publications, 1.21%
|
|
|
Annals of Nuclear Medicine
3 publications, 1.21%
|
|
|
Syndromes of Hormone Resistance on the Hypothalamic-Pituitary-Thyroid Axis
3 publications, 1.21%
|
|
|
Journal of Clinical Oncology
3 publications, 1.21%
|
|
|
The Lancet
2 publications, 0.81%
|
|
|
Endocrine-Related Cancer
2 publications, 0.81%
|
|
|
Advanced Drug Delivery Reviews
2 publications, 0.81%
|
|
|
Applied Radiation and Isotopes
2 publications, 0.81%
|
|
|
Neuroendocrinology
2 publications, 0.81%
|
|
|
Pharmaceutics
2 publications, 0.81%
|
|
|
Journal of Endocrinological Investigation
2 publications, 0.81%
|
|
|
British Journal of Cancer
2 publications, 0.81%
|
|
|
Endocrinología y Nutrición
2 publications, 0.81%
|
|
|
Best Practice and Research in Clinical Endocrinology and Metabolism
2 publications, 0.81%
|
|
|
2
4
6
8
10
12
14
16
|
Publishers
|
10
20
30
40
50
60
70
80
|
|
|
Elsevier
80 publications, 32.39%
|
|
|
Springer Nature
46 publications, 18.62%
|
|
|
Wiley
21 publications, 8.5%
|
|
|
Taylor & Francis
11 publications, 4.45%
|
|
|
American Chemical Society (ACS)
9 publications, 3.64%
|
|
|
MDPI
8 publications, 3.24%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
7 publications, 2.83%
|
|
|
The Endocrine Society
5 publications, 2.02%
|
|
|
Mary Ann Liebert
5 publications, 2.02%
|
|
|
Society of Nuclear Medicine
4 publications, 1.62%
|
|
|
American Association for Cancer Research (AACR)
4 publications, 1.62%
|
|
|
American Society of Clinical Oncology (ASCO)
3 publications, 1.21%
|
|
|
Bioscientifica
2 publications, 0.81%
|
|
|
S. Karger AG
2 publications, 0.81%
|
|
|
Frontiers Media S.A.
2 publications, 0.81%
|
|
|
Royal Society of Chemistry (RSC)
2 publications, 0.81%
|
|
|
Oxford University Press
2 publications, 0.81%
|
|
|
Hindawi Limited
2 publications, 0.81%
|
|
|
Georg Thieme Verlag KG
2 publications, 0.81%
|
|
|
Massachusetts Medical Society
1 publication, 0.4%
|
|
|
Radiological Society of North America (RSNA)
1 publication, 0.4%
|
|
|
SAGE
1 publication, 0.4%
|
|
|
Public Library of Science (PLoS)
1 publication, 0.4%
|
|
|
Jaypee Brothers Medical Publishing
1 publication, 0.4%
|
|
|
Society for Translational Oncology
1 publication, 0.4%
|
|
|
Proceedings of the National Academy of Sciences (PNAS)
1 publication, 0.4%
|
|
|
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 publication, 0.4%
|
|
|
AME Publishing Company
1 publication, 0.4%
|
|
|
BMJ
1 publication, 0.4%
|
|
|
10
20
30
40
50
60
70
80
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
247
Total citations:
247
Citations from 2025:
3
(1.21%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Otte A. et al. Yttrium-90-labelled somatostatin-analogue for cancer treatment // The Lancet. 1998. Vol. 351. No. 9100. pp. 417-418.
GOST all authors (up to 50)
Copy
Otte A., Mueller-Brand J., Dellas S., Nitzsche E., Herrmann R., Maecke H. Yttrium-90-labelled somatostatin-analogue for cancer treatment // The Lancet. 1998. Vol. 351. No. 9100. pp. 417-418.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1016/S0140-6736(05)78355-0
UR - https://doi.org/10.1016/S0140-6736(05)78355-0
TI - Yttrium-90-labelled somatostatin-analogue for cancer treatment
T2 - The Lancet
AU - Otte, Andreas
AU - Mueller-Brand, J
AU - Dellas, S
AU - Nitzsche, Eu
AU - Herrmann, R
AU - Maecke, Hr
PY - 1998
DA - 1998/02/01
PB - Elsevier
SP - 417-418
IS - 9100
VL - 351
PMID - 9482300
SN - 0140-6736
SN - 1474-547X
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{1998_Otte,
author = {Andreas Otte and J Mueller-Brand and S Dellas and Eu Nitzsche and R Herrmann and Hr Maecke},
title = {Yttrium-90-labelled somatostatin-analogue for cancer treatment},
journal = {The Lancet},
year = {1998},
volume = {351},
publisher = {Elsevier},
month = {feb},
url = {https://doi.org/10.1016/S0140-6736(05)78355-0},
number = {9100},
pages = {417--418},
doi = {10.1016/S0140-6736(05)78355-0}
}
Cite this
MLA
Copy
Otte, A., et al. “Yttrium-90-labelled somatostatin-analogue for cancer treatment.” The Lancet, vol. 351, no. 9100, Feb. 1998, pp. 417-418. https://doi.org/10.1016/S0140-6736(05)78355-0.